Seres Therapeutics Statistics

Total Valuation

MCRB has a market cap or net worth of $72.27 million. The enterprise value is $135.39 million.

Market Cap	72.27M
Enterprise Value	135.39M

Important Dates

The next confirmed earnings date is Wednesday, May 7, 2025, before market open.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

MCRB has 8.72 million shares outstanding. The number of shares has increased by 21.40% in one year.

Current Share Class	8.72M
Shares Outstanding	8.72M
Shares Change (YoY)	+21.40%
Shares Change (QoQ)	+12.23%
Owned by Insiders (%)	0.58%
Owned by Institutions (%)	23.02%
Float	6.42M

Valuation Ratios

The trailing PE ratio is 473.63.

PE Ratio	473.63
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.37
P/TBV Ratio	5.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	995.48
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 6.65.

Current Ratio	0.94
Quick Ratio	0.80
Debt / Equity	6.65
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-30.43%
Return on Invested Capital (ROIC)	-58.47%
Return on Capital Employed (ROCE)	-123.05%
Revenue Per Employee	n/a
Profits Per Employee	$1,320
Employee Count	103
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.08% in the last 52 weeks. The beta is 2.88, so MCRB's price volatility has been higher than the market average.

Beta (5Y)	2.88
52-Week Price Change	-64.08%
50-Day Moving Average	12.29
200-Day Moving Average	16.28
Relative Strength Index (RSI)	38.66
Average Volume (20 Days)	137,355

Short Selling Information

Short Interest	15.26M
Short Previous Month	16.01M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	14.45

Income Statement

Revenue	n/a
Gross Profit	-14.53M
Operating Income	-121.32M
Pretax Income	-82.68M
Net Income	136,000
EBITDA	-115.85M
EBIT	-121.32M
Earnings Per Share (EPS)	$0.02

Full Income Statement

Balance Sheet

The company has $30.79 million in cash and $91.64 million in debt, giving a net cash position of -$60.85 million or -$6.98 per share.

Cash & Cash Equivalents	30.79M
Total Debt	91.64M
Net Cash	-60.85M
Net Cash Per Share	-$6.98
Equity (Book Value)	13.78M
Book Value Per Share	1.59
Working Capital	-2.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$148.61 million and capital expenditures -$380,000, giving a free cash flow of -$148.99 million.

Operating Cash Flow	-148.61M
Capital Expenditures	-380,000
Free Cash Flow	-148.99M
FCF Per Share	-$17.09

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MCRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.40%
Shareholder Yield	-21.40%
Earnings Yield	0.18%
FCF Yield	-199.88%

Analyst Forecast

The average price target for MCRB is $80.00, which is 865.02% higher than the current price. The consensus rating is "Hold".

Price Target	$80.00
Price Target Difference	865.02%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 22, 2025. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Apr 22, 2025
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1